BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 11730279)

  • 1. Reversible MRI changes in a patient with uremic encephalopathy.
    Schmidt M; Sitter T; Lederer SR; Held E; Schiffl H
    J Nephrol; 2001; 14(5):424-7. PubMed ID: 11730279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible posterior leukoencephalopathy syndrome in a patient with severe uremic encephalopathy.
    Tatsumoto N; Fujisaki K; Nagae H; Ono-Fujisaki A; Kura-Nakamura N; Taniguchi M; Masutani K; Tsuruya K; Iida M
    Clin Nephrol; 2010 Aug; 74(2):154-8. PubMed ID: 20630137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible MRI and CT findings in uremic encephalopathy.
    Okada J; Yoshikawa K; Matsuo H; Kanno K; Oouchi M
    Neuroradiology; 1991; 33(6):524-6. PubMed ID: 1780056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cranial MRI in acute hyperammonemic encephalopathy.
    Bindu PS; Sinha S; Taly AB; Christopher R; Kovoor JM
    Pediatr Neurol; 2009 Aug; 41(2):139-42. PubMed ID: 19589465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral basal ganglia and unilateral cortical involvement in a diabetic uremic patient.
    Yoon CH; Seok JI; Lee DK; An GS
    Clin Neurol Neurosurg; 2009 Jun; 111(5):477-9. PubMed ID: 19217203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible leukoencephalopathy syndrome associated to leukopenia in a chronic hemodialysis patient.
    Salgado OJ; Rosales BC; García R
    Ther Apher Dial; 2005 Feb; 9(1):69-73. PubMed ID: 15828910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uremic encephalopathy, dialysis encephalopathy].
    Kinugasa E
    Nihon Rinsho; 2004 Jan; 62 Suppl():424-8. PubMed ID: 15011399
    [No Abstract]   [Full Text] [Related]  

  • 9. Portosystemic encephalopathy in a patient treated with peritoneal dialysis.
    Paraíso V; Francos M; Rodríguez-Berzosa F; Felipe C; López-Valdés E; Martín R; Blázquez J; Chacón C; Fidalgo A; Martín J
    Am J Kidney Dis; 2007 Jun; 49(6):854-8. PubMed ID: 17533029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uremic encephalopathy in patients undergoing assisted peritoneal dialysis: a case series and literature review.
    Yanai A; Uchiyama K; Ishibashi Y
    CEN Case Rep; 2019 Nov; 8(4):271-279. PubMed ID: 31177383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysis disequilibrium syndrome and other treatment complications of extreme uremia: a rare occurrence yet not vanished.
    Lopez-Almaraz E; Correa-Rotter R
    Hemodial Int; 2008 Jul; 12(3):301-6. PubMed ID: 18638082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathophysiological aspects of neurological complications in renal failure.
    De Deyn PP; Saxena VK; Abts H; Borggreve F; D'Hooge R; Marescau B; Crols R
    Acta Neurol Belg; 1992; 92(4):191-206. PubMed ID: 1332359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of uremic patients by automated peritoneal dialysis: study of 78 cases].
    Karoui C; Ben Hamida F; Cherif M; Barbouch S; Kaaroud H; Ounissi M; Abderrahim E; Ben Abdallah T; Ben Moussa F; Ben Maiz H; Kheder A
    Tunis Med; 2007 Mar; 85(3):225-9. PubMed ID: 17668579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propafenone pharmacokinetics in uremic patients treated by peritoneal dialysis.
    Poirier JM; Joannides R; Geffroy-Josse S; Fillastre JP; Etienne I
    Clin Nephrol; 1992 Oct; 38(4):231-2. PubMed ID: 1424311
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cerebral lesions in acute arterial hypertension: the characteristic MRI in hypertensive encephalopathy].
    Schneider JP; Krohmer S; Günther A; Zimmer C
    Rofo; 2006 Jun; 178(6):618-26. PubMed ID: 16703498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral cortical laminar necrosis on diffusion-weighted MRI in hypoglycaemic encephalopathy.
    Yoneda Y; Yamamoto S
    Diabet Med; 2005 Aug; 22(8):1098-100. PubMed ID: 16026379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain dysfunction in uremia: a question of cortical hyperexcitability?
    Battaglia F; Quartarone A; Bagnato S; Rizzo V; Morgante F; Floccari F; Romeo A; Sant'Angelo A; Grasso G; Girlanda P; Buemi M
    Clin Neurophysiol; 2005 Jul; 116(7):1507-14. PubMed ID: 15908270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterior reversible encephalopathy syndrome caused by hypertensive encephalopathy and acute uremia.
    Gokce M; Dogan E; Nacitarhan S; Demirpolat G
    Neurocrit Care; 2006; 4(2):133-6. PubMed ID: 16627901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Continuous ambulatory peritoneal dialysis: determination of treatment location].
    Rambausek M
    Dtsch Med Wochenschr; 1990 Dec; 115(51-52):1975-9. PubMed ID: 2261863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.